Unexpectedly high toxicity of MACOP‐B in young patients with low grade lymphoma
- 1 September 1991
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 38 (1) , 75-76
- https://doi.org/10.1002/ajh.2830380115
Abstract
We report the results of treatment with MACOP‐B in 11 young patients with low grade lymphoma (LGL). Complete remission was obtained in 4 (57%) and partial remission in 3 (42.8%) of 7 evaluable patients. However, this aggressive chemotherapy has not offered any advantage because of an unacceptably high treatment‐related morbidity and mortality (17%). Serious infection during neutropenia was the most common complication.Keywords
This publication has 9 references indexed in Scilit:
- Interpretation of clinical trials in diffuse large-cell lymphoma.Journal of Clinical Oncology, 1988
- Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.Journal of Clinical Pathology, 1987
- MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell LymphomaAnnals of Internal Medicine, 1985
- The Natural History of Initially Untreated Low-Grade Non-Hodgkin's LymphomasNew England Journal of Medicine, 1984
- Prolonged Initial Remission in Patients with Nodular Mixed LymphomaAnnals of Internal Medicine, 1984
- No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic TypesAnnals of Internal Medicine, 1979
- Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.BMJ, 1978